Answer
The most common injection-site reactions to IXCHIQ in clinical studies were tenderness (10.8%) and pain (6.1%).
Sources for this answer
- IXCHIQ Chikungunya vaccine (live)Valneva UK Limited · emc · SmPC §4.8 Undesirable effects · Version 1Document updated
Sources checked